Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02717156
Title Recombinant EphB4-HSA Fusion Protein and Pembrolizumab in Treating Patients With Metastatic or Recurrent Urothelial Cancer That Is Refractory to Certain Chemotherapy Drugs
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
LAC+USC Medical Center RECRUITING Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
USC Norris Oncology/Hematology - Newport Beach RECRUITING Newport Beach California 92663 United States Details
UC Davis Comprehensive Cancer Center RECRUITING Sacramento California 95817 United States Details
University of Kansas Cancer Center RECRUITING Kansas City Kansas 66205 United States Details
Comprehensive Cancer Centers of Nevada RECRUITING Las Vegas Nevada 89169 United States Details
Levine Cancer Institute-Carolinas Medical Center RECRUITING Charlotte North Carolina 28277 United States Details
University of Virginia Cancer Center RECRUITING Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field